RG-12915 is primarily utilized in research settings, particularly in the field of neuroscience and pharmacology. It is often studied for its potential effects on neurotransmitter systems, especially those involving dopamine receptors. Researchers investigate its role in modulating dopamine-related pathways, which can provide insights into the treatment of neurological and psychiatric disorders such as Parkinson's disease, schizophrenia, and addiction. Its application in experimental studies helps in understanding the mechanisms of dopamine receptor interactions and the development of novel therapeutic agents targeting these pathways. Additionally, RG-12915 may be used in behavioral studies to assess its impact on motor function, cognition, and reward systems, contributing to a broader understanding of brain function and drug development.